1. A stabilized pharmaceutical composition comprising! allergen protein and! at least one type of stabilizer selected from the group consisting of sugars, sugar alcohols and sugar fatty acids. ! 2. The stabilized pharmaceutical composition according to claim 1, in which! additionally contains water, and! the stabilizer includes at least one type of stabilizer selected from the group consisting of D-sorbitol, isosalt, sucrose, raffinose, fatty acid esters and sorbitan and fatty acid esters and sucrose. ! 3. The stabilized pharmaceutical composition according to claim 1, in which,! essentially no water, and! the stabilizer includes D-mannitol. ! 4. The liquid formulation of the stabilized pharmaceutical composition obtained using the stabilized pharmaceutical composition according to claim 2. ! 5. The preparative form in the form of a film obtained using the stabilized pharmaceutical composition according to claim 3, which further comprises a polysaccharide. ! 6. The preparative form in the form of a film according to claim 5, in which! the polysaccharide includes hydroxypropyl cellulose. ! 7. A method of obtaining a preparative form in the form of a film, including! obtaining a liquid dispersion containing an allergen protein, hydroxypropyl cellulose, D-mannitol and a polar organic solvent； ! the formation of a thin film of liquid dispersion and! drying a thin film.1. Стабилизированная фармацевтическая композиция, включающая ! белок-аллерген и ! по меньшей мере один тип стабилизатора, выбранного из группы, состоящей из сахаров, сахаров-спиртов и сахаров жирных кислот. ! 2. Стабилизированная фармацевтическая композиция по п.1, в которой ! дополнительно содержится вода, и ! стабилизатор включает по меньшей мере один тип стабилизатора, выбранного из группы, состоящей из D-сорбита, изосолода, сахарозы, раффинозы, эфиров жирных кислот и сорбитана и эфиров жирных кислот и сахарозы. ! 3. Стабилизированная фармацевтическая композиция по п.1, в которой, ! по существу,
